Research progress on berberine with a special focus on its oral bioavailability

Fitoterapia

Volumn 109, Issue , 2016, Pages 274-282

  Liu, Chang Shun ^a   Zheng, Yu Rong ^a   Zhang, Ying Feng ^a   Long, Xiao Ying ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Absorption; Berberine; First pass effect; Oral bioavailability; Pharmacokinetics; Pharmacological activities

Indexed keywords

BERBERINE;

ANIMAL; BIOAVAILABILITY; CHEMICAL STRUCTURE; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIAS; NEOPLASMS; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; BERBERINE; BIOLOGICAL AVAILABILITY; DIABETES MELLITUS; HUMANS; HYPERLIPIDEMIAS; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 84957586715     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2016.02.001     Document Type: Review

References (127)

1. I. Kosalec, B. Gregurek, D. Kremer, M. Zovko, K. Sanković, and K. Karlović Croatian barberry (Berberis croatica Horvat): a new source of berberine - analysis and antimicrobial activity World J. Microbiol. Biotechnol. 25 1 2009 145 150
2. Y. Chang Effectiveness of berberine in bacillary dysentery Zhonghua Nei Ke Za Zhi 7 1959 741 743
3. X. Xia, H. Wang, X. Niu, H. Wang, Z. Liu, Y. Liu, and et al. Assessment of the anti-diarrhea function of compound Chinese herbal medicine cangpo oral liquid Afr. J. Tradit. Complement. 11 1 2013 140 147
4. X.W. Jiang, Y. Zhang, Y.L. Zhu, H. Zhang, K. Lu, F.F. Li, and et al. Effects of berberine gelatin on recurrent aphthous stomatitis: a randomized, placebo-controlled, double-blind trial in a Chinese cohort Oral Surg. Oral Med. Oral Pathol. 115 2 2013 212 217
5. H.L. Li, T. Han, R.H. Liu, C. Zhang, H.S. Chen, and W.D. Zhang Alkaloids from Corydalis saxicola and their anti-hepatitis B virus activity Chem. Biodivers. 5 5 2008 777 783
6. Q. Zhang, X. Xiao, K. Feng, T. Wang, W. Li, T. Yuan, and et al. Berberine moderates glucose and lipid metabolism through multipathway mechanism Evid-Based Complement Alternat 2011 2011 1 10
7. Z. Zhang, H. Zhang, B. Li, X. Meng, J. Wang, Y. Zhang, and et al. Berberine activates thermogenesis in white and brown adipose tissue Nat. Commun. 5 2014 5493
8. H.L. Wu, T.Y. Chuang, A. Al-Hendy, M.P. Diamond, R. Azziz, and Y.H. Chen Berberine inhibits the proliferation of human uterine leiomyoma cells Fertil. Steril. 103 4 2015 1098 1106
9. A. Refaat, S. Abdelhamed, I. Saiki, and H. Sakurai Inhibition of p38 mitogen-activated protein kinase potentiates the apoptotic effect of berberine/tumor necrosis factor-related apoptosis-inducing ligand combination therapy Oncol. Lett. 10 3 2015 1907 1911
10. Y.T. Liu, H.P. Hao, H.G. Xie, L. Lai, Q. Wang, C.X. Liu, and et al. Extensive intestinal first-pass elimination and predominant hepatic distribution of berberine explain its low plasma levels in rats Drug Metab. Dispos. 38 10 2010 1779 1784
11. W. Chen, Y. Miao, D. Fan, S. Yang, X. Lin, L. Meng, and et al. Bioavailability study of berberine and the enhancing effects of TPGS on intestinal absorption in rats AAPS PharmSciTech 12 2 2011 705 711
12. G.H. Rabbani, T. Butler, J. Knight, S.C. Sanyal, and K. Alam Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae J. Infect. Dis. 155 5 1987 979 984
13. C. Chen, C. Tao, Z. Liu, M. Lu, Q. Pan, L. Zheng, and et al. A randomized clinical trial of berberine hydrochloride in patients with diarrhea-predominant irritable bowel syndrome Phytother. Res. 29 11 2015 1822 1827
14. E.A. Swabb, Y.H. Tai, and L. Jordan Reversal of cholera toxin-induced secretion in rat ileum by luminal berberine Am. J. Phys. 241 3 1981 G248 G252
15. J. Yuan, X.Z. Shen, and X.S. Zhu Effect of berberine on transit time of human small intestine Zhongguo Zhong Xi Yi Jie He Za Zhi 14 12 1994 718 720
16. E.Y. Eaker, and C.A. Sninsky Effect of berberine on myoelectric activity and transit of the small intestine in rats Gastroenterology 96 6 1989 1506 1513
17. N. Li, L. Gu, L. Qu, J. Gong, Q. Li, W. Zhu, and et al. Berberine attenuates pro-inflammatory cytokine-induced tight junction disruption in an in vitro model of intestinal epithelial cells Eur. J. Pharm. Sci. 40 1 2010 1 8
18. K. Karaosmanoglu, N.A. Sayar, I.A. Kurnaz, and B.S. Akbulut Assessment of berberine as a multi-target antimicrobial: a multi-omics study for drug discovery and repositioning OMICS 18 1 2014 42 53
19. M.L. Freile, F. Giannini, G. Pucci, A. Sturniolo, L. Rodero, O. Pucci, and et al. Antimicrobial activity of aqueous extracts and of berberine isolated from Berberis heterophylla Fitoterapia 74 7-8 2003 702 705
20. S. Bandyopadhyay, P.H. Patra, A. Mahanti, D.K. Mondal, P. Dandapat, S. Bandyopadhyay, and et al. Potential antibacterial activity of berberine against multi drug resistant enterovirulent Escherichia coli isolated from yaks (Poephagus grunniens) with haemorrhagic diarrhoea Asian Pac. J. Trop. Med. 6 4 2013 315 319
21. Q. Xie, B.R. Johnson, C.S. Wenckus, M.I. Fayad, and C.D. Wu Efficacy of berberine, an antimicrobial plant alkaloid, as an endodontic irrigant against a mixed-culture biofilm in an in vitro tooth model J. Endod. 38 8 2012 1114 1117
22. M. Cernakova, and D. Kostalova Antimicrobial activity of berberine - a constituent of Mahonia aquifolium Folia Microbiol. 47 4 2002 375 378
23. S.H. Kim, D.S. Shin, M.N. Oh, S.C. Chung, J.S. Lee, and K.B. Oh Inhibition of the bacterial surface protein anchoring transpeptidase sortase by isoquinoline alkaloids Biosci. Biotechnol. Biochem. 68 2 2004 421 424
24. G.K. Paterson, and T.J. Mitchell The biology of Gram-positive sortase enzymes Trends Microbiol. 12 2 2004 89 95
25. M. Chu, R. Ding, Z.Y. Chu, M.B. Zhang, X.Y. Liu, S.H. Xie, and et al. Role of berberine in anti-bacterial as a high-affinity LPS antagonist binding to TLR4/MD-2 receptor BMC Complement. Altern. Med. 14 2014 89
26. S.K. Battu, M.A. Repka, S. Maddineni, A.G. Chittiboyina, M.A. Avery, and S. Majumdar Physicochemical characterization of berberine chloride: a perspective in the development of a solution dosage form for oral delivery AAPS PharmSciTech 11 3 2010 1466 1475
27. X. Xie, H. Huang, W. Li, T. Lan, W. Liu, J. Peng, and et al. Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway Endocr. J. 58 9 2011 761 768
28. H. Dong, N. Wang, L. Zhao, and F. Lu Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis Evid-Based Complement Alternat 2012 2012 1 12
29. J. Yin, H. Xing, and J. Ye Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism 57 5 2008 712 717
30. H. Zhang, J. Wei, R. Xue, J. Wu, W. Zhao, Z. Wang, and et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression Metabolism 59 2 2010 285 292
31. N. Shen, Y. Huan, and Z.F. Shen Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic beta-cell Eur. J. Pharmacol. 694 1-3 2012 120 126
32. W. Kong, H. Zhang, D. Song, R. Xue, W. Zhao, J. Wei, and et al. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression Metabolism 58 1 2009 109 119
33. A. Cok, C. Plaisier, M.J. Salie, D.S. Oram, J. Chenge, and L.L. Louters Berberine acutely activates the glucose transport activity of GLUT1 Biochimie 93 7 2011 1187 1192
34. W. Abbud, S. Habinowski, J.Z. Zhang, J. Kendrew, F.S. Elkairi, B.E. Kemp, and et al. Stimulation of AMP-activated protein kinase (AMPK) is associated with enhancement of Glut1-mediated glucose transport Arch. Biochem. Biophys. 380 2 2000 347 352
35. S.H. Kim, E.J. Shin, E.D. Kim, T. Bayaraa, S.C. Frost, and C.K. Hyun Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes Biol. Pharm. Bull. 30 11 2007 2120 2125
36. S.J. Jiang, H. Dong, J.B. Li, L.J. Xu, X. Zou, K.F. Wang, and et al. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats World J. Gastroenterol. 21 25 2015 7777 7785
37. X. Xia, J. Yan, Y. Shen, K. Tang, J. Yin, Y. Zhang, and et al. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis PLoS One 6 2 2011 e16556
38. J. Yin, Z. Gao, D. Liu, Z. Liu, and J. Ye Berberine improves glucose metabolism through induction of glycolysis Am. J. Physiol. Endocrinol. Metab. 294 1 2008 E148 E156
39. J. Zhang, Z. Guo, Z. Xue, Z. Sun, M. Zhang, L. Wang, and et al. A phylo-functional core of gut microbiota in healthy young Chinese cohorts across lifestyles, geography and ethnicities ISME J. 9 9 2015 1979 1990
40. X. Zhang, Y. Zhao, J. Xu, Z. Xue, M. Zhang, X. Pang, and et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats Sci. Rep. 5 2015 14405
41. W. Xie, D. Gu, J. Li, K. Cui, and Y. Zhang Effects and action mechanisms of berberine and Rhizoma Coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice PLoS One 6 9 2011 e24520
42. X. Zhang, Y. Zhao, M. Zhang, X. Pang, J. Xu, C. Kang, and et al. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats PLoS One 7 8 2012 e42529
43. F. Cabreiro, C. Au, K.Y. Leung, N. Vergara-Irigaray, H.M. Cocheme, T. Noori, and et al. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism Cell 153 1 2013 228 239
44. N.R. Shin, J.C. Lee, H.Y. Lee, M.S. Kim, T.W. Whon, M.S. Lee, and et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice Gut 63 5 2014 727 735
45. J.A. Marin-Neto, B.C. Maciel, A.L. Secches, and J.L. Gallo Cardiovascular effects of berberine in patients with severe congestive heart failure Clin. Cardiol. 11 4 1988 253 260
46. X.X. Chang, H.M. Yan, Q. Xu, M.F. Xia, H. Bian, T.F. Zhu, and et al. The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet Lipids Health Dis. 11 2012 86
47. M. Brown, and J. Goldstein A receptor-mediated pathway for cholesterol homeostasis (Nobel Lecture) Science 25 7 1986 583 602
48. J.L. Goldstein, and M.S. Brown Regulation of the mevalonate pathway Nature 343 6257 1990 425 430
49. W. Kong, J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, and et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins Nat. Med. 10 12 2004 1344 1351
50. H. Li, W. Chen, Y. Zhou, P. Abidi, O. Sharpe, W.H. Robinson, and et al. Identification of mRNA binding proteins that regulate the stability of LDL receptor mRNA through AU-rich elements J. Lipid Res. 50 5 2009 820 831
51. P. Abidi, Y. Zhou, J.D. Jiang, and J. Liu Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine Arterioscler. Thromb. Vasc. Biol. 25 10 2005 2170 2176
52. H. Li, B. Dong, S.W. Park, H.S. Lee, W. Chen, and J. Liu Hepatocyte nuclear factor 1alpha plays a critical role in PCSK9 gene transcription and regulation by the natural hypocholesterolemic compound berberine J. Biol. Chem. 284 42 2009 28885 28895
53. J. Cameron, T. Ranheim, M.A. Kulseth, T.P. Leren, and K.E. Berge Berberine decreases PCSK9 expression in HepG2 cells Atherosclerosis 201 2 2008 266 273
54. Y. Wang, X. Yi, K. Ghanam, S. Zhang, T. Zhao, and X. Zhu Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption Metabolism 63 9 2014 1167 1177
55. Y. Wang, X. Jia, K. Ghanam, C. Beaurepaire, J. Zidichouski, and L. Miller Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters Atherosclerosis 209 1 2010 111 117
56. X. Li, Z. Zhao, M. Huang, R. Feng, C. He, C. Ma, and et al. Effect of berberine on promoting the excretion of cholesterol in high-fat diet-induced hyperlipidemic hamsters J. Transl. Med. 13 1 2015 278
57. T. Carbonell, and E. Freire Binding thermodynamics of statins to HMG-CoA reductase Biochemistry-Us 44 35 2005 11741 11748
58. MRC/BHF. Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 9326 2002 7 22
59. B. Liu, G. Wang, J. Yang, X. Pan, Z. Yang, and L. Zang Berberine inhibits human hepatoma cell invasion without cytotoxicity in healthy hepatocytes PLoS One 6 6 2011 e21416
60. L. Wang, L. Liu, Y. Shi, H. Cao, R. Chaturvedi, M.W. Calcutt, and et al. Berberine induces caspase-independent cell death in colon tumor cells through activation of apoptosis-inducing factor PLoS One 7 5 2012 e36418
61. W. He, B. Wang, Y. Zhuang, D. Shao, K. Sun, and J. Chen Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells J. Pharmacol. Sci. 119 4 2012 341 348
62. Y. Ho, J. Yang, T. Li, J. Lin, J. Lin, K. Lai, and et al. Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF-κB, u-PA and MMP-2 and -9 Cancer Lett. 279 2 2009 155 162
63. S. Spinozzi, C. Colliva, C. Camborata, M. Roberti, C. Ianni, F. Neri, and et al. Berberine and its metabolites: relationship between physicochemical properties and plasma levels after administration to human subjects J. Nat. Prod. 77 4 2014 766 772
64. Y. Liu, H. Hao, H. Xie, H. Lv, C. Liu, and G. Wang Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats J. Pharm. Sci.-Us 98 11 2009 4391 4401
65. Z. Gong, Y. Chen, R. Zhang, Y. Wang, Y. Guo, Q. Yang, and et al. Pharmacokinetic comparison of berberine in rat plasma after oral administration of berberine hydrochloride in normal and post inflammation irritable bowel syndrome rats Int. J. Mol. Sci. 15 1 2014 456 467
66. R. Feng, J. Shou, Z. Zhao, C. He, C. Ma, M. Huang, and et al. Transforming berberine into its intestine-absorbable form by the gut microbiota Sci. Rep. 5 2015 12155
67. X. Tan, J. Ma, R. Feng, C. Ma, W. Chen, Y. Sun, and et al. Tissue distribution of berberine and its metabolites after oral administration in rats PLoS One 8 10 2013 e77969
68. Y. Guo, F. Li, X. Ma, X. Cheng, H. Zhou, and C.D. Klaassen CYP2D plays a major role in berberine metabolism in liver of mice and humans Xenobiotica 41 11 2011 996 1005
69. Y. Li, G. Ren, Y. Wang, W. Kong, P. Yang, Y. Wang, and et al. Bioactivities of berberine metabolites after transformation through CYP450 isoenzymes J. Transl. Med. 9 1 2011 62
70. F. Zuo, N. Nakamura, T. Akao, and M. Hattori Pharmacokinetics of berberine and its main metabolites in conventional and pseudo germ-free rats determined by liquid chromatography/ion trap mass spectrometry Drug Metab. Dispos. 34 12 2006 2064 2072
71. B. Tan, Y. Ma, R. Shi, and T. Wang Simultaneous quantification of three alkaloids of Coptidis Rhizoma in rat urine by high-performance liquid chromatography: application to pharmacokinetic study Biopharm. Drug Dispos. 28 9 2007 511 516
72. C.M. Chen, and H.C. Chang Determination of berberine in plasma, urine and bile by high-performance liquid chromatography J. Chromatogr. B Biomed. Appl. 665 1 1995 117 123
73. P.L. Tsai, and T.H. Tsai Hepatobiliary excretion of berberine Drug Metab. Dispos. 32 4 2004 405 412
74. W. Hua, L. Ding, Y. Chen, B. Gong, J. He, and G. Xu Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry J. Pharm. Biomed. 44 4 2007 931 937
75. U. Fagerholm, M. Johansson, and H. Lennernas Comparison between permeability coefficients in rat and human jejunum Pharm. Res. 13 9 1996 1336 1342
76. W. Chen, D. Fan, L. Meng, Y. Miao, S. Yang, Y. Weng, and et al. Enhancing effects of chitosan and chitosan hydrochloride on intestinal absorption of berberine in rats Drug Dev. Ind. Pharm. 38 1 2012 104 110
77. T. Bansal, G. Mishra, M. Jaggi, R.K. Khar, and S. Talegaonkar Effect of P-glycoprotein inhibitor, verapamil, on oral bioavailability and pharmacokinetics of irinotecan in rats Eur. J. Pharm. Sci. 36 4-5 2009 580 590
78. H.A. Bardelmeijer, M. Ouwehand, T. Buckle, M.T. Huisman, J.H. Schellens, J.H. Beijnen, and et al. Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir Cancer Res. 62 21 2002 6158 6164
79. X. Zhang, F. Qiu, J. Jiang, C. Gao, and Y. Tan Intestinal absorption mechanisms of berberine, palmatine, jateorhizine, and coptisine: involvement of P-glycoprotein Xenobiotica 41 4 2011 290 296
80. G.Y. Pan, G.J. Wang, X.D. Liu, J.P. Fawcett, and Y.Y. Xie The involvement of P-glycoprotein in berberine absorption Pharmacol. Toxicol. 91 4 2002 193 197
81. J. Ma, R. Feng, X. Tan, C. Ma, J. Shou, J. Fu, and et al. Excretion of berberine and its metabolites in oral administration in rats J. Pharm. Sci.-Us 102 11 2013 4181 4192
82. Z. Li, Y. Wei, and T. Chu Radioiodination, biodistribution and pharmacokinetics of berberine in mice J. Radioanal. Nucl. Chem. 265 3 2005 355 359
83. S.P. Joel, P.I. Clark, and M.L. Slevin Stability of the i.v. and oral formulations of etoposide in solution Cancer Chemother. Pharmacol. 37 1-2 1995 117 124
84. A.E. van Herwaarden, R.A. van Waterschoot, and A.H. Schinkel How important is intestinal cytochrome P450 3A metabolism? Trends Pharmacol. Sci. 30 5 2009 223 227
85. G.R. Wilkinson Drug metabolism and variability among patients in drug response N. Engl. J. Med. 352 21 2005 2211 2221
86. S. Rendic, and F. Di Carlo Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors Drug Metab. Rev. 29 4 1997 413 580
87. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F. Guengerich Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J. Pharmacol. Exp. Ther. 270 1 1994 414 423
88. D. Fan, X. Wu, W. Dong, W. Sun, J. Li, and X. Tang Enhancement by sodium caprate and sodium deoxycholate of the gastrointestinal absorption of berberine chloride in rats Drug Dev. Ind. Pharm. 39 9 2013 1447 1456
89. J. Zhu, D. Tang, L. Feng, Z. Zheng, R. Wang, A. Wu, and et al. Development of self-microemulsifying drug delivery system for oral bioavailability enhancement of berberine hydrochloride Drug Dev. Ind. Pharm. 39 3 2013 499 506
90. B.J. Aungst Intestinal permeation enhancers J. Pharm. Sci. 89 4 2000 429 442
91. E.K. Anderberg, T. Lindmark, and P. Artursson Sodium caprate elicits dilatations in human intestinal tight junctions and enhances drug absorption by the paracellular route Pharm. Res. 10 6 1993 857 864
92. X. Lv, J. Li, M. Zhang, C. Wang, Z. Fan, C. Wang, and et al. Enhancement of sodium caprate on intestine absorption and antidiabetic action of berberine AAPS PharmSciTech 11 1 2010 372 382
93. M. Zhang, X. Lv, J. Li, Z. Meng, Q. Wang, W. Chang, and et al. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis Mol. Cell. Endocrinol. 363 1-2 2012 122 130
94. M. Zhaojie, Z. Ming, W. Shengnan, B. Xiaojia, G.M. Hatch, G. Jingkai, and et al. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability Int. J. Pharm. 467 1-2 2014 50 59
95. S. Maher, T.W. Leonard, J. Jacobsen, and D.J. Brayden Safety and efficacy of sodium caprate in promoting oral drug absorption: from in vitro to the clinic Adv. Drug Deliv. Rev. 61 15 2009 1427 1449
96. M.J. Cano-Cebrian, T. Zornoza, L. Granero, and A. Polache Intestinal absorption enhancement via the paracellular route by fatty acids, chitosans and others: a target for drug delivery Curr. Drug Deliv. 2 1 2005 9 22
97. P. Artursson, T. Lindmark, S.S. Davis, and L. Illum Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2) Pharm. Res. 11 9 1994 1358 1361
98. Y. Kato, H. Onishi, and Y. Machida Application of chitin and chitosan derivatives in the pharmaceutical field Curr. Pharm. Biotechnol. 4 5 2003 303 309
99. N.G. Schipper, K.M. Varum, P. Stenberg, G. Ocklind, H. Lennernas, and P. Artursson Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement Eur. J. Pharm. Sci. 8 4 1999 335 343
100. T. Bansal, N. Akhtar, M. Jaggi, R.K. Khar, and S. Talegaonkar Novel formulation approaches for optimising delivery of anticancer drugs based on P-glycoprotein modulation Drug Discov. Today 14 21-22 2009 1067 1074
101. M.M. Malingre, J.H. Beijnen, H. Rosing, F.J. Koopman, O. van Tellingen, K. Duchin, and et al. A phase I and pharmacokinetic study of bi-daily dosing of oral paclitaxel in combination with cyclosporin A Cancer Chemother. Pharmacol. 47 4 2001 347 354
102. M.M. Malingre, D.J. Richel, J.H. Beijnen, H. Rosing, F.J. Koopman, B.H.W. Ten, and et al. Coadministration of cyclosporine strongly enhances the oral bioavailability of docetaxel J. Clin. Oncol. 19 4 2001 1160 1166
103. A.W. Alani, D.A. Rao, R. Seidel, J. Wang, J. Jiao, and G.S. Kwon The effect of novel surfactants and Solutol HS 15 on paclitaxel aqueous solubility and permeability across a Caco-2 monolayer J. Pharm. Sci. 99 8 2010 3473 3485
104. T.R. Buggins, P.A. Dickinson, and G. Taylor The effects of pharmaceutical excipients on drug disposition Adv. Drug Deliv. Rev. 59 15 2007 1482 1503
105. S. Zhou, L.Y. Lim, and B. Chowbay Herbal modulation of P-glycoprotein Drug Metab. Rev. 36 1 2004 57 104
106. L. Fu, Y. Liang, L. Deng, Y. Ding, L. Chen, Y. Ye, and et al. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance Cancer Chemother. Pharmacol. 53 4 2004 349 356
107. Z.L. Liu, T. Hirano, S. Tanaka, K. Onda, and K. Oka Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells J. Pharm. Pharmacol. 55 11 2003 1531 1537
108. S.H. Wu, and W.K. Hopkins Characteristics of d-α-tocopheryl PEG1000 succinate for applications as an absorption enhancer in drug delivery systems Pharm. Technol. 23 1999 52 68
109. J.M. Dintaman, and J.A. Silverman Inhibition of P-glycoprotein by d-alphatocopheryl polyethylene glycol 1000 succinate (TPGS) Pharm. Res. 16 1999 1550 1556
110. K. Bogman, F. Erne-Brand, J. Alsenz, and J. Drewe The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins J. Pharm. Sci. 92 6 2003 1250 1261
111. G. Cornaire, J. Woodley, P. Hermann, A. Cloarec, C. Arellano, and G. Houin Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo Int. J. Pharm. 278 1 2004 119 131
112. B.D. Rege, J.P. Kao, and J.E. Polli Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers Eur. J. Pharm. Sci. 16 4-5 2002 237 246
113. L. Yu, A. Bridgers, J. Polli, A. Vickers, S. Long, A. Roy, and et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability Pharm. Res. 16 12 1999 1812 1817
114. 2: preparation, characterization and in vivo studies Int. J. Pharm. 465 1-2 2014 306 316
115. F. Di Pierro, I. Bellone, G. Rapacioli, and P. Putignano Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins Diabetes Metab. Syndr. Obes. 8 2015 89 96
116. F. Di Pierro, N. Villanova, F. Agostini, R. Marzocchi, V. Soverini, and G. Marchesini Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control Diabetes Metab. Syndr. Obes. 5 2012 213 217
117. G. Derosa, A. Bonaventura, L. Bianchi, D. Romano, A. D'Angelo, E. Fogari, and et al. Berberis aristata/Silybum marianum fixed combination on lipid profile and insulin secretion in dyslipidemic patients Expert. Opin. Biol. Ther. 13 11 2013 1495 1506
118. G. Derosa, A. Bonaventura, L. Bianchi, D. Romano, A. D'Angelo, E. Fogari, and et al. Effects of Berberis aristata/Silybum marianum association on metabolic parameters and adipocytokines in overweight dyslipidemic patients J. Biol. Regul. Homeost. Agents 27 3 2013 717 728
119. F. Di Pierro, P. Putignano, N. Villanova, L. Montesi, S. Moscatiello, and G. Marchesini Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes Clin. Pharmacol. 5 2013 167 174
120. Y.Q. Shan, Y.P. Zhu, J. Pang, Y.X. Wang, D.Q. Song, W.J. Kong, and et al. Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function Biol. Pharm. Bull. 36 10 2013 1562 1569
121. Y. Shan, G. Ren, Y. Wang, J. Pang, Z. Zhao, J. Yao, and et al. Berberine analogue IMB-Y53 improves glucose-lowering efficacy by averting cellular efflux especially P-glycoprotein efflux Metabolism 62 3 2013 446 456
122. Y.H. Li, P. Yang, W.J. Kong, Y.X. Wang, C.Q. Hu, Z.Y. Zuo, and et al. Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy J. Med. Chem. 52 2 2009 492 501
123. P. Yang, D.Q. Song, Y.H. Li, W.J. Kong, Y.X. Wang, L.M. Gao, and et al. Synthesis and structure-activity relationships of berberine analogues as a novel class of low-density-lipoprotein receptor up-regulators Bioorg. Med. Chem. Lett. 18 16 2008 4675 4677
124. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh Lipid - an emerging platform for oral delivery of drugs with poor bioavailability Eur. J. Pharm. Biopharm. 73 1 2009 1 15
125. R.H. Muller, D. Ruhl, S. Runge, K. Schulze-Forster, and W. Mehnert Cytotoxicity of solid lipid nanoparticles as a function of the lipid matrix and the surfactant Pharm. Res. 14 4 1997 458 462
126. M. Xue, M. Yang, W. Zhang, X. Li, D. Gao, Z. Ou, and et al. Characterization, pharmacokinetics, and hypoglycemic effect of berberine loaded solid lipid nanoparticles Int. J. Nanomedicine 8 2013 4677
127. T. Wang, N. Wang, H. Song, X. Xi, J. Wang, A. Hao, and et al. Preparation of an anhydrous reverse micelle delivery system to enhance oral bioavailability and anti-diabetic efficacy of berberine Eur. J. Pharm. Sci. 44 1-2 2011 127 135